Treatment of subarachnoid hemorrhage: the ability of epsilon aminocaproic acid to cross the blood brain barrier and reduce the spinal fluid fibrinolytic activity.
D000614:Aminocaproates / Q000097:blood / Q000134:cerebrospinal fluid / Q000627:therapeutic use*; D001812:Blood-Brain Barrier; D002555:Cerebrospinal Fluid / Q000503:physiopathology*; D002852:Chromatography, Ion Exchange; D002854:Chromatography, Paper; D005342:Fibrinolysis; D006801:Humans; D013345:Subarachnoid Hemorrhage / Q000188:drug therapy*
D000614:Aminocaproates